Low major adverse cardiac event rates following bioresorbable vascular scaffold implantation: Impact of implantation technique on treatment outcomes.

As per the multivariate Cox regression, BVS undersizing (Hazard ratio [HR] 2.65, 95% CI: 1.27–5.53, p = 0.009) and number of implanted scaffolds (HR 1.33, 95% CI: 1.04–1.70, p = 0.024) were independent predictors of MACE, with a significant trend also emerging for diabetes mellitus (HR 1.93, 95% CI: 0.98–3.79, p = 0.056). 14 The high MACE rates could also be attributed to lack of consistent use of Absorb optimal implantation techniques across various centers participating in the trial. 11 Furthermore, there was a clustering of definite/prob

also in 9,775 other papers